Purpose <p>Males and females with First Episode Psychosis (FEP) usually tend to differ in psychopathology, clinical presentation and their longitudinal trajectory. This study aimed to examine the difference of effectiveness of specialized psychosocial and pharmacological treatments for FEP, focusing on various clinical and functioning outcomes across a 2-years follow-up period.</p> Methods <p>The assessment included the CAARMS, the HoNOS, the PANSS and the GAF scale and was conducted at baseline and every 12&#xa0;months.</p> Results <p>490 FEP patients (age: 12–35&#xa0;years) were recruited. Of them, 363 completed the follow-up (132 females and 231 males). At baseline, males showed a higher prevalence rate of schizophrenia diagnosis (56.1% VS 43.8%; <i>p</i> = .008), whereas females a higher prevalence rate of affective psychosis (36.2% VS 23.3%; <i>p</i> = .005). Male participants also showed a more consistent substance abuse (46.9% VS 24.3%; <i>p</i> = .0001), lower years of education (11.26 ± 2.94 VS 11.88 ± 2.68; <i>p</i> = .013), and more striking behavioral manifestations (4.06 ± 2.36 VS 3.39 ± 2.58; <i>p</i> = .003) compared to women. Our 2-year outcome parameter results showed a higher incidence of functional remission over time in females compared to males (49.2% VS 39.0%; <i>p</i> = .028), together with a decreasing trend in new hospitalization rates (17.8% VS 26.9%; <i>p</i> = .089). Independently from sex, our results also showed a statistically significant reduction in the prescription of psychotropic medications and through the increase of all psychosocial interventions, although more evident in males.</p> Conclusion <p>These results suggested that specialized interventions for FEP are overall effective in both treated subgroups. Additionally, FEP women specifically showed higher rates of improvement in functional outcome variables over time when compared to males.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Sex comparisons on the beneficial effects of an early intervention program in a patients’ cohort with first episode psychosis: what effectiveness in women?

  • Lorenzo Pelizza,
  • Camilla Ricci,
  • Emanuela Leuci,
  • Emanuela Quattrone,
  • Derna Palmisano,
  • Simona Pupo,
  • Giuseppina Paulillo,
  • Clara Pellegrini,
  • Pietro Pellegrini,
  • Marco Menchetti

摘要

Purpose

Males and females with First Episode Psychosis (FEP) usually tend to differ in psychopathology, clinical presentation and their longitudinal trajectory. This study aimed to examine the difference of effectiveness of specialized psychosocial and pharmacological treatments for FEP, focusing on various clinical and functioning outcomes across a 2-years follow-up period.

Methods

The assessment included the CAARMS, the HoNOS, the PANSS and the GAF scale and was conducted at baseline and every 12 months.

Results

490 FEP patients (age: 12–35 years) were recruited. Of them, 363 completed the follow-up (132 females and 231 males). At baseline, males showed a higher prevalence rate of schizophrenia diagnosis (56.1% VS 43.8%; p = .008), whereas females a higher prevalence rate of affective psychosis (36.2% VS 23.3%; p = .005). Male participants also showed a more consistent substance abuse (46.9% VS 24.3%; p = .0001), lower years of education (11.26 ± 2.94 VS 11.88 ± 2.68; p = .013), and more striking behavioral manifestations (4.06 ± 2.36 VS 3.39 ± 2.58; p = .003) compared to women. Our 2-year outcome parameter results showed a higher incidence of functional remission over time in females compared to males (49.2% VS 39.0%; p = .028), together with a decreasing trend in new hospitalization rates (17.8% VS 26.9%; p = .089). Independently from sex, our results also showed a statistically significant reduction in the prescription of psychotropic medications and through the increase of all psychosocial interventions, although more evident in males.

Conclusion

These results suggested that specialized interventions for FEP are overall effective in both treated subgroups. Additionally, FEP women specifically showed higher rates of improvement in functional outcome variables over time when compared to males.